On MedHeads Friday, we covered everything from Dr. Patrick Soon-Shiong’s continued funding for NantBioscience, our site’s exciting new redesign and other trends from the week. Watch the broadcast above, but also review five of the more important topics we looked at this week. 1. Bigfoot Biomedical’s artificial pancreas is emerging from hack mode with a […]
Today's MedHeads broadcast will address Patrick Soon-Shiong, our site redesign and other topics of interest from the week.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Billionaire investor Patrick Soon-Shiong buys the rights to a next-gen Abraxane from Sorrento Therapeutics - building on the drug that launched his own fortune.
More funding for billionaire Patrick Soon-Shiong’s NantBioscience has been reported to the SEC – to the tune of $100 million this time. NantBioscience is the division of Soon-Shiong’s umbrella company, NantWorks, that centers on precision medicine. Los Angeles-based NantWorks has more than $1 billion in funding behind it since its launch last year, but it’s interesting to […]
Billionaire surgeon Patrick Soon-Shiong has developed quite the high profile – regarded as a kind of Tony Stark of health care. His hush-hush startup, NantHealth, has attracted hundreds of millions in capital to improve cancer care through precision diagnostics – but the startup is now under scrutiny for being “engaged in a multitude of fraudulent activities.” […]
NantBioscience – the personalized medicine subsection of the extraordinarily funded Patrick Soon-Shiong-led startup NantWorks – reported in SEC filings that it’s raised $25 million. This comes soon after the umbrella company’s announcement of a mega-funding deal – in early October it received $320 million in funding, and $250 million of that is from the Kuwait […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Given billionaire Patrick Soon-Shiong’s general save-the-world M.O., it’s always worth tracking what his companies are up to. NantBioScience, an offshoot of his Los Angeles startup NantWorks, has partnered up with University of Colorado to develop protein-targeted anti-cancer drugs and diagnostics. The licensing deal is exclusive, and focuses on the Ral protein – which plays a role across activated signaling pathways in pancreatic, lung, colon and other […]